Is oxidative stress a therapeutic target in cardiovascular disease?

Area of Science:

• Cardiovascular Science
• Oxidative Stress Research
• Vascular Biology

Background:

• Endothelial dysfunction is linked to increased reactive oxygen species (ROS) and reduced nitric oxide (NO) bioavailability.
• Cardiovascular risk factors like diabetes and hypertension exacerbate this imbalance, promoting atherosclerosis via peroxynitrite formation.
• Classical antioxidant trials (e.g., Vitamin E) have yielded disappointing results in improving vascular function.

Purpose of the Study:

• To review the role of oxidative stress in endothelial dysfunction.
• To evaluate the efficacy of different therapeutic strategies targeting oxidative stress.
• To identify future directions for cardiovascular prevention and therapy.

Main Methods:

• Literature review of studies on oxidative stress, endothelial dysfunction, and cardiovascular disease.
• Analysis of pre-clinical and clinical evidence for antioxidant therapies and other interventions.
• Synthesis of findings regarding the sources of superoxide and their impact on nitric oxide.

Main Results:

• Direct antioxidant interventions have largely failed to demonstrate significant clinical benefits.
• Pharmacological agents with indirect antioxidant effects, such as statins and ACE inhibitors, improve vascular function and reduce cardiovascular events.
• These effective agents enhance NO production while inhibiting superoxide generation, particularly from NADPH oxidase.

Conclusions:

• Oxidative stress remains a critical target for cardiovascular prevention, but its complex role requires deeper understanding.
• Indirect antioxidant strategies that modulate NO and superoxide balance are more effective than direct antioxidant supplementation.
• Further research into the sources and specific roles of ROS in vascular pathology is needed for developing novel therapeutic approaches.